EHA 2019 Chinmay Munje, MD, PhD

Chinmay Munje, MD, PhD from the Paul O’Gorman Leukaemia Research Centre, Glasgow, UK is commenting on the publication "COMBINATION OF ASCIMINIB (ABL001) WITH ATP-COMPETITIVE TYROSINE KINASE INHIBITORS TARGETS EARLY CML PROGENITOR CELLS", which was presented at EHA 2019 in Amsterdam

Reference: EHA Library. BARRACO F. Jun 14, 2019; 266478

https://library.ehaweb.org/eha/2019/24th/266478/fiorenza.barraco.real-world.safety.data.from.a.noninterventional.long-term.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3DREAL-WORLD+SAFETY+DATA+FROM+A+NONINTERVENTIONAL+LONG-TERM+POSTAUTHORIZATION+SAFETY+STUDY+OF+RUXOLITINIB+IN+MYELOFIBROSIS

Related items